Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers
Abstract Nasal decolonization procedures against the opportunistic pathogen Staphylococcus aureus rely on topical antimicrobial drug usage, whose impact on the nasal microbiota is poorly understood. We examined this impact in healthy S. aureus carriers and noncarriers. This is a prospective interven...
Main Authors: | Valérie O. Baede, Anaïs Barray, Mehri Tavakol, Gérard Lina, Margreet C. Vos, Jean-Philippe Rasigade |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-21453-4 |
Similar Items
-
Mupirocin prophylaxis for the prevention of nosocomial infections due to nasal carriers of Staphylococcus aureus is of no use in nonsurgical patients as yet
by: Wertheim, H, et al.
Published: (2005) -
Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery.
by: Miranda M L van Rijen, et al.
Published: (2012-01-01) -
Antibacterial Effect of Zinc Oxide Nanoparticles on Mupirocin-Resistant Staphylococcus aureus Isolated From Nasal Carriers
by: Afsaneh Hajimohammad, et al.
Published: (2018-06-01) -
Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
by: Wertheim, H, et al.
Published: (2005) -
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
by: Wertheim, H, et al.
Published: (2005)